Meditope Biosciences, Inc. — Form D
Meditope Biosciences, Inc. of PASADENA, CA, a company, filed a Form D exempt-offering notice with the SEC on 2013-02-27. The offering totals $4.0M, of which $2.1M was reported sold. Industry: Biotechnology.
Offering
- Filed: 2013-02-27
- Form: D
- Accession: 0001567712-13-000003
- Industry: Biotechnology
- Exemptions: 06
- Total offering: $4.0M
- Amount sold: $2.1M
- Remaining: $1.9M
- Investors: 14
- Date of first sale: 2013-02-26
- Security types: equity
- Revenue range: Decline to Disclose
- SEC file number: 021-192460
Issuer
- Name: Meditope Biosciences, Inc.
- CIK: 0001567712
- Entity type: Corporation
- Jurisdiction: DELAWARE
- Incorporated: 2011
- Address: 301 N. LAKE AVENUE, PASADENA, CA, 91101
- Phone: 626-278-2478
Officers, directors & promoters (7)
| Name | Role | Location |
|---|
| Michael Goldberg | Director | Weston, CT |
| Stephanie Hsieh | Director | Houston, TX |
| Stephanie Hsieh | Executive Officer | Houston, TX |
| Rob Kramer | Director | New York, NY |
| Heng Wei Chang | Director | Pasadena, CA |
| Robert McKenzie | Director | Pasadena, CA |
| George Prendergast | Director | Pasadena, CA |
Other filings by this issuer (1)
More